CVS Health Corporation (NYSE:CVS) Quarterly growth Review

Henrietta Strickland
October 13, 2017

CVS's profit will be $1.51B for 12.40 P/E if the $1.49 EPS becomes a reality. After having $0.75 EPS previously, Mesa Laboratories, Inc.'s analysts see -24.00% EPS growth. About 349,706 shares traded. Mobileye NV (NYSE:MBLY) has risen 70.86% since October 12, 2016 and is uptrending. It has outperformed by 8.78% the S&P500.

Lipe & Dalton increased Cvs Health Corp (CVS) stake by 18.22% reported in 2017Q2 SEC filing.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Seekingalpha.com which released: "CVS Health Is In A Great Position To Excel" on October 06, 2017, also Benzinga.com with their article: "Jim Cramer Advises His Viewers On CVS Health Corp And Brink's Company" published on September 29, 2017, Prnewswire.com published: "CVS Health Corporation Announces Quarterly Dividend" on September 19, 2017.

Shares of CVS Health Corporation (NYSE:CVS) traded down 0.18% during mid-day trading on Thursday, hitting $73.77. HDP's SI was 3.42M shares in October as released by FINRA. It has underperformed by 41.10% the S&P500.

Investors sentiment decreased to 0.92 in Q2 2017. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.31 by $0.02. It dived, as 84 investors sold CVS shares while 559 reduced holdings.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. The stock rose 0.14% or $0.1 reaching $74 per share. California-based Cheviot Value Management Limited Liability Company has invested 1.75% in CVS Health Corp (NYSE:CVS). Colony Grp Incorporated Ltd Limited Liability Company reported 200,639 shares. Guggenheim reaffirmed a "buy" rating on shares of CVS Health Corporation in a report on Monday, July 3rd. CVS Health Corp (NYSE:CVS) has declined 24.40% since October 12, 2016 and is downtrending. Retail Bank has invested 0.25% of its portfolio in CVS Health Corp (NYSE:CVS). Country Club Na holds 1% in CVS Health Corp (NYSE:CVS) or 85,056 shares. Kentucky Retirement Sys Insurance Fund has invested 0.4% in CVS Health Corp (NYSE:CVS). Bragg Fincl Advsr invested in 32,125 shares.

CVS Health Corporation (CVS) reported sales (ttm) of 180.79 Billion, whereas, 19 number of analysts estimated the mean sale of 47678.7 million.

Cls Investments Llc increased its stake in Now Inc (DNOW) by 346.78% based on its latest 2017Q2 regulatory filing with the SEC. Duff Phelps Inv Mgmt Com has 11,855 shares. Mutual Of America Capital Management Ltd Liability stated it has 124,271 shares or 0.17% of all its holdings. 20,495 were reported by Martin & Tn.

Since June 12, 2017, it had 0 insider purchases, and 1 insider sale for $18.44 million activity. Sentry Investments has 5.52M shares. First Long Island Invsts Ltd Liability Corp invested in 224,664 shares or 2.8% of the stock. Therefore 57% are positive. Citigroup Inc. lowered their price target on CVS Health Corporation from $88.00 to $87.00 and set a "neutral" rating for the company in a report on Thursday, August 17th. Also, EVP Thomas M. Moriarty sold 20,547 shares of the business's stock in a transaction on Monday, October 2nd. The rating was maintained by Jefferies with "Hold" on Friday, September 15. Finally, BidaskClub downgraded CVS Health Corporation from a "hold" rating to a "sell" rating in a research report on Friday, August 25th. JP Morgan maintained it with "Overweight" rating and $123 target in Monday, November 2 report. On Thursday, May 12 the stock rating was maintained by Jefferies with "Buy". The stock of CVS Health Corp (NYSE:CVS) has "Hold" rating given on Friday, September 8 by Needham. The rating was downgraded by Robert W. Baird on Thursday, February 2 to "Neutral". Its up 0.07, from 1.69 in 2017Q1. The stock has a market cap of $75.12 billion, a PE ratio of 14.72 and a beta of 0.92. SRS Capital Advisors Inc. raised its position in CVS Health Corporation by 48.2% during the first quarter. Finemark Bancorporation Tru accumulated 3,094 shares or 0.06% of the stock. Washington-based Parametric Portfolio Associate Limited Liability Corporation has invested 0% in Mesa Laboratories, Inc. Perkins Cap Mngmt owns 0.47% invested in Hortonworks Inc (NASDAQ:HDP) for 32,675 shares. (NASDAQ:MLAB). Comml Bank Of Montreal Can, Ontario - Canada-based fund reported 17 shares. Paloma Prns Mngmt Company has invested 0% in Hortonworks Inc (NASDAQ:HDP). (NASDAQ:HA) shares. Okinaka Shannon Lei sold 2,500 shares worth $53,210. 15,972 are owned by Dumont And Blake Investment Limited Company. (NASDAQ:HA) for 4,028 shares. Sei Investments has invested 0% of its portfolio in Mesa Laboratories, Inc. Cypress Asset Mgmt Tx owns 26,670 shares for 0.44% of their portfolio. Crawford Investment Counsel owns 0.11% invested in Mesa Laboratories, Inc. Winslow Evans Crocker accumulated 0% or 16,964 shares. Pathstone Family Office Ltd Liability Corporation reported 0.02% stake. Alyeska Investment Gru LP holds 149,507 shares or 0.36% of its portfolio. Out of 4 Wall Street analysts rating Mead Johnson Nutrition, 0 give it "Buy", 1 "Sell" rating, while 3 recommend "Hold".

Since May 1, 2017, it had 1 buy, and 1 sale for $102,593 activity. In the last three months, insiders have sold 716,625 shares of company stock worth $58,318,431. 230,510 shares valued at $18.44 million were sold by Denton David M on Monday, June 12. The rating was maintained by Stifel Nicolaus with "Buy" on Friday, July 14.

Mesa Laboratories, Inc.is focused primarily on quality control services and products. The company has market cap of $129.68 million. The Firm is engaged in the scheduled air transportation of passengers and cargo amongst the Hawaiian Islands, between the Hawaiian Islands and certain cities in the United States (the North America routes), and between the Hawaiian Islands and the South Pacific, Australia, New Zealand and Asia (the worldwide routes), collectively referred to as its Scheduled Operations. The industry's and sector's high P/E for the past year is 113.68 and 31.67 respectively and low P/E ratio for the last 5 years is 6.78 for the industry and 10.26 for the Sector.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER